Insmed (INSM) Tax Provisions (2010 - 2026)
Insmed (INSM) recorded quarterly Tax Provisions of $1.5 million in Q1 2026, down 5.54% quarter-over-quarter from $1.6 million in Q4 2025, and up 62.78% on a YoY basis from $900000.0 in Q1 2025.
Insmed (INSM) Tax Provisions (2010 - 2026) Analysis & Trends
Insmed's Tax Provisions history runs 16 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 62.78% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $5.6 million (up 37.67% YoY), while the FY2025 annual figure was $5.0 million, up 35.84% from the prior year.
- Tax Provisions was $1.5 million for Q1 2026 at Insmed, down from $1.6 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.6 million in Q4 2025 to a low of $83000.0 in Q4 2022.
- Historically, Tax Provisions has averaged $830117.6 across 5 years, with a median of $838000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions slipped 16.5% in 2022, then jumped 1104.82% in 2023.
- A 5-year view of Tax Provisions shows it stood at $83000.0 in 2022, then surged by 1104.82% to $1.0 million in 2023, then rose by 30.0% to $1.3 million in 2024, then advanced by 19.31% to $1.6 million in 2025, then declined by 5.54% to $1.5 million in 2026.
- The last three Tax Provisions figures came in at $1.5 million (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 838,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 544,000.00 |
| Jun 30, 2023 | 530,000.00 |
| Mar 31, 2023 | 483,000.00 |
| Dec 31, 2022 | 83,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 501,000.00 |
| Mar 31, 2022 | 385,000.00 |
| Dec 31, 2021 | -83,000.00 |
| Sep 30, 2021 | -2.58 Mn |
| Jun 30, 2021 | 600,000.00 |